nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives

Prostate cancer (PC) is one of the most frequently diagnosed cancers and the second-leading cause of cancer death in adult males, globally [1]. Most PC related deaths are associated with metastatic widespread, a condition which can occur either at diagnosis (about 5-10% of cases) or after disease relapse following local treatments (radical prostatectomy and/or radiation therapy). PC may relapse as biochemical recurrence in absence of distant metastases, a condition also known as “biochemical failure”, mainly treated with salvage radiotherapy.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Anti-tumour Treatment Source Type: research